The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate
Open accessThe DOI matches its Crossref record.
Abstract
Two active forms (Mr 45,000 and 28,000) of a metalloendopeptidase that digest proteoglycans and other extracellular matrix components of connective tissues have previously been purified from rheumatoid synovial cells and characterized [Okada, Nagase & Harris (1986) J. Biol. Chem. 261, 14245-14255]. To study the mechanisms of activation the precursor of this metalloendopeptidase has now been purified. The final products are homogeneous on SDS/polyacrylamide-gel electrophoresis and identified as a set of zymogens of Mr 57,000 and 59,000, in which the latter form is probably the product of post-translational glycosylation of the Mr 57,000 zymogen, as it binds to concanavalin A. The zymogen can be activated by trypsin, chymotrypsin, plasma kallikrein, plasmin and thermolysin, but not by thrombin. Although the activated metalloendopeptidase is further degraded by trypsin, plasma kallikrein and thermolysin during a prolonged incubation, it is relatively stable against plasmin and chymotrypsin. Activation with 4-aminophenylmercuric acetate is dependent on its concentration. It requires the reaction with the zymogen, possibly through thiol groups, and the continued presence of the agent. During this treatment the zymogen undergoes a sequential processing; first it becomes active without changing its apparent molecular mass, and then it is processed to low-Mr species of Mr 46,000, 45,000 (HMM) and 28,000 (LMM). The rate of conversion of the precursor into an initial intermediate of Mr 46,000 follows first-order kinetics (t1/2 2.0 h with 1.5 mM-4-amino-phenylmercuric acetate at 37 degrees C) and is independent of the initial concentration of the zymogen or the presence of up to a 676-fold molar excess of substrate, whereas the generation of HMM and LMM species is affected by these parameters. These results indicate that activation of the prometalloendopeptidase by an organomercurial compound is initiated by the molecular perturbation of the zymogen that results in conversion into the 46,000-Mr intermediate by an intramolecular action; the subsequent processing of this intermediate in HMM and LMM species is a bimolecular reaction. In vivo it is probable that the precursor of this metalloendopeptidase is activated either by direct limited proteolysis by tissue or plasma endopeptidases, or, alternatively, by factors that cause certain conformational changes in the zymogen molecule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Self-citationMatrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
Self-citationOhuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Self-citationOgata, Y., Enghild, J. J., & Nagase, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50563-4 · Cited by 627
Self-citationOkada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., & Hayakawa, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36670-0 · Cited by 501
Self-citationMolecular mechanisms for the conversion of zymogens to active proteolytic enzymes
Khan, A. R., & James, M. N. G. (1998) · Protein Science · doi:10.1002/pro.5560070401 · Cited by 471
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
Self-citationOKADA, Y., MORODOMI, T., ENGHILD, J. J., SUZUKI, K., YASUI, A., NAKANISHI, I., SALVESEN, G., & NAGASE, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19462.x · Cited by 429
Self-citationNagase, H., Enghild, J. J., Suzuki, K., & Salvesen, G. (1990) · Biochemistry · doi:10.1021/bi00476a020 · Cited by 389
Self-citationGruber, B. L., Marchese, M. J., Suzuki, K., Schwartz, L. B., Okada, Y., Nagase, H., & Ramamurthy, N. S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114344 · Cited by 348
Self-citationHashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E., & Okada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201674200 · Cited by 339
Self-citationBecker, J. W., Marcy, A. I., Rokosz, L. L., Axel, M. G., Burbaum, J. J., Fitzgerald, P. M. D., Cameron, P. M., Esser, C. K., Hagmann, W. K., Hermes, J. D., et al. (1995) · Protein Science · doi:10.1002/pro.5560041002 · Cited by 293
Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells
Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., & Okada, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6691 · Cited by 285
Self-citationCuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 268
Walakovits, L. A., Moore, V. L., Bhardwaj, N., Gallick, G. S., & Lark, M. W. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350106 · Cited by 257
Okada, Y., Takeuchi, N., Tomita, K., Nakanishi, I., & Nagase, H. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.8.645 · Cited by 199
Self-citationVaillant, C., Didier-Bazès, M., Hutter, A., Belin, M.-F., & Thomasset, N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04994.1999 · Cited by 188
“Gelatinase activity in the developing and adult rat cerebellum MMPs are expressed and secreted as inactive precursors that are activated by the removal of an N-terminal propeptide (Okada et al., 1988).”
BackgroundLEES, M., TAYLOR, D. J., & WOOLLEY, D. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18980.x · Cited by 178
Metadata
- Authors
- Okada, Y., Harris, E. D., & Nagase, H.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1988-09-15
- Volume
- 254
- Issue
- 3
- Pages
- 731-741
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W635471586
- Cited by
- 142
- References
- 0
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.